EEF1A2 and ovarian neoplasm: High levels of eEF1A2 expression was observed in 30% all the primary ovarian tumors, 50% of serous tumors, 30% of endometrioid tumors, 19% of mucinous tumors, and 8% of clear-cell tumors (Table 2) (56).